Found: 34
Select item for more details and to access through your institution.
Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival.
- Published in:
- Angewandte Chemie, 2019, v. 131, n. 15, p. 89, doi. 10.1111/bjh.15749
- By:
- Publication type:
- Article
A national service for delivering CD19 CAR‐Tin large B‐cell lymphoma – The UK real‐world experience.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. 492, doi. 10.1111/bjh.18209
- By:
- Publication type:
- Article
COSMIC, c hemotherapy plus o fatumumab at s tandard or m ega‐dose i n c hronic lymphocytic leukaemia, a phase II randomised study.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 646, doi. 10.1111/bjh.17526
- By:
- Publication type:
- Article
SARS‐CoV‐2 screening for asymptomatic health care workers in UK stem cell transplant units.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 2, p. e37, doi. 10.1111/bjh.17196
- By:
- Publication type:
- Article
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post‐BCR inhibitor setting: a UK wide analysis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 656, doi. 10.1111/bjh.15802
- By:
- Publication type:
- Article
Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 1, p. 89, doi. 10.1111/bjh.15749
- By:
- Publication type:
- Article
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 5, p. 782, doi. 10.1111/bjh.15691
- By:
- Publication type:
- Article
Idelalisib‐rituximab induces durable remissions in TP53 disrupted B‐PLL but results in significant toxicity: updated results of the UK‐wide compassionate use programme.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 667, doi. 10.1111/bjh.15151
- By:
- Publication type:
- Article
Guideline for the treatment of chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 344, doi. 10.1111/bjh.15460
- By:
- Publication type:
- Article
A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 429, doi. 10.1111/bjh.14793
- By:
- Publication type:
- Article
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 555, doi. 10.1111/bjh.14665
- By:
- Publication type:
- Article
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: a report from the EBMT Lymphoma Working Party.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 1, p. 86, doi. 10.1111/bjh.15152
- By:
- Publication type:
- Article
Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 5, p. 790, doi. 10.1111/bjh.14962
- By:
- Publication type:
- Article
NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 1, p. 43, doi. 10.1111/bjh.14177
- By:
- Publication type:
- Article
Recent advances in therapy of chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 3, p. 351, doi. 10.1111/bjh.14184
- By:
- Publication type:
- Article
Survival outcomes and treatment costs for patients with double-refractory chronic lymphocytic leukaemia ( DR- CLL).
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 449, doi. 10.1111/bjh.13224
- By:
- Publication type:
- Article
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 628, doi. 10.1002/ajh.26833
- By:
- Publication type:
- Article
Long‐term follow‐up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide‐based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. E168, doi. 10.1002/ajh.26483
- By:
- Publication type:
- Article
RFP represses transcriptional activation by bHLH transcription factors.
- Published in:
- Oncogene, 2005, v. 24, n. 45, p. 6729, doi. 10.1038/sj.onc.1208828
- By:
- Publication type:
- Article
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1252811
- By:
- Publication type:
- Article
Fatal invasive aspergillosis of the larynx.
- Published in:
- European Journal of Haematology, 2013, v. 90, n. 4, p. 354, doi. 10.1111/ejh.12054
- By:
- Publication type:
- Article
Cerebral tuberculosis post stem cell transplant.
- Published in:
- 2006
- By:
- Publication type:
- Other
Acquired thrombasthenia due to GPIIbIIIa platelet autoantibodies in a 4-yr-old child.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Evolving Risk Factors for Mortality, Progression, Myeloid Dysplasia and Survival in Large 2-Decade Single-Centre Autologous Transplant Cohort of Myeloma, Amyloidosis and related Plasma Cell Dyscrasia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e288, doi. 10.1016/j.clml.2019.09.474
- By:
- Publication type:
- Article
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Allogeneic stem cell transplantation for acquired pure red cell aplasia.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. E294, doi. 10.1002/ajh.25609
- By:
- Publication type:
- Article
Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph‐negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 6, p. 778, doi. 10.1002/ajh.25091
- By:
- Publication type:
- Article
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 40, doi. 10.1002/ajh.24927
- By:
- Publication type:
- Article
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 4, p. 519, doi. 10.1111/j.1365-2141.2011.08711.x
- By:
- Publication type:
- Article
Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-14829-5
- By:
- Publication type:
- Article